The Usefulness of CD34, PCNA Immunoreactivity, and Histopathological Findings for Prediction of Pain Persistence After the Removal of Endometrioma

Akın Usta, Akin Usta, Gulay Turan, Gülay Turan, Eren Altun, Meryem Hocaoğlu, Meryem Hocaoglu, Çağla Bahar Bülbül, Cagla Bahar Bulbul, Ertan Adali, Ertan Adalı
Reproductive sciences (Thousand Oaks, Calif.) · 2018 · vol. 26(2) , pp. 269–277 · doi:10.1177/1933719118768697 · PMID:29642800 · W2797089754
article OA: closed CC0 ⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_painendometrioma

MeSH descriptors

Antigens, CD34 Endometriosis Endometrium Pelvic Pain Proliferating Cell Nuclear Antigen Adult Antigens, CD34 Endometriosis Endometriosis Endometriosis Endometrium Endometrium Endometrium Female Humans Immunohistochemistry Pelvic Pain Pelvic Pain Pelvic Pain Prognosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (36)

Cited by (1)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:19:49.066213+00:00
License: CC0 · commercial use OK